Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges

Jaime Castillo-León*, Ramona Trebbien, John J. Castillo, Winnie E. Svendsen

*Corresponding author for this work

Research output: Contribution to journalReviewpeer-review

Abstract

The ongoing COVID-19 pandemic has shown the importance of having analytical devices that allow a simple, fast, and robust detection of pathogens which cause epidemics and pandemics. The information these devices can collect is crucial for health authorities to make effective decisions to contain the disease's advance. The World Health Organization published a list of primary pathogens that have raised concern as potential causes of future pandemics. Unfortunately, there are no rapid diagnostic tests commercially available and approved by the regulatory bodies to detect most of the pathogens listed by the WHO. This report describes these pathogens, the available detection methods, and highlights areas where more attention is needed to produce rapid diagnostic tests for future pandemic surveillance.
Original languageEnglish
JournalAnalyst
Volume146
Issue number12
Pages (from-to)3750-3776
Number of pages28
ISSN0003-2654
DOIs
Publication statusPublished - 2021

Fingerprint Dive into the research topics of 'Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges'. Together they form a unique fingerprint.

Cite this